EBITDA Growth
8920.60%
TTM · Period ending:
PCRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported8920.60%period ending
Latest reported8920.60%period ending
PCRX TTM EBITDA YoY % (-23.45% → 8920.60%)
Year-over-year change
High-resolution chart · PNG
PCRX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 8,920.5995% | |
| 322.4684% | |
| 320.7123% | |
| 342.2733% | |
| -100.6995% | |
| -85.0533% | |
| -81.1638% | |
| -72.5167% | |
| 61.7083% | |
| 77.2855% | |
| 10.1197% | |
| -9.891% | |
| -18.061% | |
| -16.3569% | |
| 23.1946% | |
| 10.9831% | |
| 36.7226% | |
| 84.7359% | |
| 79.4077% | |
| 161.7807% | |
| 131.2372% | |
| 27.7706% | |
| 54.5879% | |
| -10.8388% | |
| -1.1334% | |
| 22.0574% | |
| 18.4444% | |
| 73.9218% | |
| 100.0535% | |
| 5,213.5593% | |
| 427.5234% | |
| 231.0411% | |
| 154.4881% | |
| 102.4639% | |
| 42.1983% | |
| -32.8606% | |
| -876.5881% | |
| -427.799% | |
| -246.4668% | |
| -182.4832% | |
| -68.8326% | |
| -29.0924% | |
| 189.9189% | |
| 242.8278% | |
| 162.0367% | |
| 138.4736% | |
| 108.7408% | |
| 72.065% | |
| 50.4201% | |
| 26.3569% | |
| -16.815% | |
| -24.9659% | |
| -58.4646% | |
| -39.0391% | |
| -29.0618% | |
| -58.3715% | |
| -42.4516% | |
| -74.1521% | |
| -77.052% | |
| -28.8446% | |
| -23.4453% |